Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Joseph, Deokary ^a,c   Kabanywanyi, Abdunoor M ^b   Hulser, Ruth ^c   Premji, Zulfiqarali ^d   Minzi, Omary M S ^d   Mugittu, Kefas ^b  

^a UNIVERSITY OF DAR ES SALAAM   (Tanzania)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c St Phillip's Health Centre   (Tanzania)

^d MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG BLOOD LEVEL; DRUG EFFICACY; FOLLOW UP; GAMETOCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PRESCHOOL CHILD; SCHOOL CHILD; TANZANIA; TREATMENT RESPONSE;

ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PLASMA; TANZANIA; TREATMENT OUTCOME;

EID: 84873495543     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-60     Document Type: Article

References (38)

1. WHO, Guidelines for Malaria Treatment Geneva: World Health Organization 2006 http://whqlibdoc.who.int/publications/2006/9241546948-eng.pdf
2. Combination therapy for malaria in Africa: hype or hope? Bloland PB, Ettling M, Meek S, Bull World Health Organ 2000 78 1378 1388 11196485
3. Artesunate combinations for treatment of malaria: meta analysis. Adjuik MA, Babiker A, Garner P, Olliaro P, Taylor W, White N, Lancet 2004 363 9 17 14723987
4. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S, Malar J 2007 6 146 10.1186/1475-2875-6-146 17996121
5. Artemisinin-resistant malaria in Asia. Noedl H, Socheat D, Satimai W, NEJM 2009 361 540 541 10.1056/NEJMc0900231 19641219
6. Declining in efficacy of athree-day combination regimenof mefloquine-artesunate in multidrug resistance area alon the Thai-Mynmar Border. Na-Bangchang K, Ruengweerayut R, Mahamad P, Ruenweerayut K, Chaijaroenkul W, Malar J 2010 9 273 10.1186/1475-2875-9-273 20929590
7. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
8. A major genome region underlying artemisinin resistance in malaria. Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Phyo AP, Moo CL, Lwin KM, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig MT, Anderson TJ, Science 2012 336 79 82 10.1126/science.1215966 22491853
9. Confirmed malaria cases among children underfive with fever and history of fever in rural western Tanzania. Mazigo HD, Meza W, Ambrose EE, Kidenya BR, Kweka EJ, BMC Research Notes 2011 4 359 10.1186/1756-0500-4-359 21914203
10. WHO, Methods for Surveillance of Antimalarial Drug Efficacy Geneva: World Health Organization 2009
11. Sample size of 12 per group rule of thumb for a pilot study. Julious S, Pharm Stat 2005 4 287 291 10.1002/pst.185
12. Interlaboratory development and cross validation of a chromatographic method for determination of lumefantrine in human plasma-a proficient capacity assessment of bioanalytical laboratories in East. Minzi OMS, Sasi P, Mareale I, J Anal Bioanal Techniques 2012 3 2
13. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Eh JP, Chongsuphajaisiddhi T, White NJ, J Infect Dis 1994 170 971 977 10.1093/infdis/170.4.971 7930743
14. Effects of artemisinin derivatives on malaria transmissibility. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, Lancet 1996 347 1654 1658 10.1016/S0140-6736(96)91488-9 8642959
15. WHO, Global Plan for Artemisinin Resistance Containment (GPARC Geneva, Switzerland: World Health Organization 2011 http://www.who.int/malaria/ publications/atoz/artemisinin-resistance-containment-2011.pdf
16. High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. Guthmann J-P, Cohuet S, Rigutto C, Fortes F, Saraiva N, Kiguli J, Kyomuhendo J, Francis M, Noel F, Mulemba M, Balkan S, AmJTrop Med Hyg 2006 75 143 145
17. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. van den Broek I, Kitz C, Attas SA, Libama F, Balasegaram M, Guthmann JP, Malar J 2006 5 113 10.1186/1475-2875-5-113 17125496
18. Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Eastern Nepal. Thapa S, Hollander J, Linehan M, Cox-Singh J, Bista MB, Thakur GD, Davis WAand Davis TME, AmJTrop Med Hyg 2007 77 423- 430
19. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Faye B, Ndiaye J-L, Ndiaye D, Dieng Y, Faye O, Gaye O, Malar J 2007 6 80 10.1186/1475-2875-6-80 17570848
20. High efficacy of two artemisinin-based combinations (artemether- lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. Falade CO, Ogundele AO, Yusuf BO, Ademowo OG, Ladipo SM, Trop Med Int Health 2008 13 635 643 10.1111/j.1365-3156.2008.02043.x 18346028
21. Guidelines and mindlines: why do clinical staffs over-diagnose malaria in Tanzania?A qualitative study. Chandler CIR, Jones C, Boniface G, Juma K, Reyburn H, Whitty CJM, Malar J 2008 7 53 10.1186/1475-2875-7-53 18384669
22. Malaria misdiagnosis in Uganda-implications for policy change. Nankabirwa J, Zurovac D, Njogu JN, Rwakimari JB, Counihan H, Snow RW, Tibenderana JK, Malar J 2009 8 66 10.1186/1475-2875-8-66 19371426
23. Treatment with Coartem (Artemether-Lumefantrine) in Papua New Guinea. Schoepflin S, Lin E, Kiniboro B, DaRe JT, Mehlotra RK, Zimmerman PA, Mueller I, Felger I, AmJTrop Med Hyg 2010 82 529 534 10.4269/ajtmh.2010.09-0334
24. WHO, Guidelines for the Treatment of Malaria Geneva, Switzerland: World Health Organization second 2010
25. Preventing antimalarial drug resistance through combinations. White NJ, Drug Resist Updat 1998 1 3 9 10.1016/S1368-7646(98)80208-2 17092790
26. In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia. Hwang J, Alemayehu BH, Hoos D, Melaku Z, Tekleyohannes SG, Teshi T, Birhanu SG, Demeke L, Gobena K, Kassa M, Jima D, Reithinger R, Nettey H, Green M, Malone JL, Kachur SP, Filler S, Malar J 2011 10 209 10.1186/1475-2875-10-209 21798054
27. Efficacy and safety of CGP56697(artemether andn benflumetol) compared with chloroquine to treat acute falciparum malaria inTanzania children aged 1-5 years. Hatz C, Abdulla S, Mull R, Schellenberg D, Gathmann I, Kibatala P, Beck HP, Tanner MRC, Trop Med Int Health 1998 3 498 504 10.1046/j.1365-3156.1998. 00250.x 9657513
28. Therapeutic efficacy of artemether/lumefantrine (Coartem®) against Plasmodium falciparum inKersa, South West Ethiopia. Assefa A, Kassa M, Tadese G, Mohamed H, Animut A, Mengesha T, Parasit Vectors 2010 3 1 10.1186/1756-3305-3-1 20051120
29. Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania. Akim JIN, Drakeley C, Kingo TB, Senkoro K, Sauerwein RW, AmJTrop Med Hyg 2000 63 199 203
30. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, Nash D, Singhasivanon P, Anderson TJ, Krishna S, White NJ, Nosten F, Clin Infect Dis 2006 42 1570 1577 10.1086/503423 16652314
31. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. Bousema JT, Schneider P, Gouagna LC, Drakeley Chris J, Tostmann A, Houben R, Githure Ord R, Sutherland CJ, Omar SA, Sauerwein RW, J Infect Dis 2006 193 1151 9 10.1086/503051 16544256
32. Reduction of malaria transmission to anopheles mosquitoes with a six-dose regimen of co-artemether. Southerland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GAT, PLoS Med 2005 2 92 10.1371/journal.pmed.0020092 15839740
33. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Barnes KI, Chanda P, Barnabas G, Malar J 2009 8 1 8 10.1186/1475-2875-8-S1-S8 19917078
34. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley C, Malar J 2010 9 136 10.1186/1475-2875-9-136 20497536
35. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NPJ, Malar J 2009 8 253 10.1186/1475-2875-8-253 19906307
36. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ, Malar J 2008 7 125 10.1186/1475-2875-7-125 18613962
37. Artesunate reduces but does not prevent post treatment transmission of Plasmodium falciparum to Anopheles gambiae. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, Pinder M, Doherty T, Sutherland C, Walraven G, Milligan P, J Infect Dis 2001 183 1254 1259 10.1086/319689 11262208
38. Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance. Michael OS, Gbotosho GO, Folarin OA, Okuboyejo T, Sowunmi A, Oduola AM, Happi CT, Malar J 2010 9 335 10.1186/1475-2875-9-335 21092220